Core Laboratories N.V.

NYSE: CLB · Real-Time Price · USD
10.61
-0.13 (-1.21%)
At close: Aug 14, 2025, 3:59 PM
10.60
-0.09%
After-hours: Aug 14, 2025, 05:54 PM EDT

Core Laboratories Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
523.85M 509.79M 489.74M 470.25M
Cost of Revenue
435.48M 415.74M 410.82M 386.41M
Gross Profit
88.37M 94.05M 78.92M 83.84M
Operating Income
58.56M 54.64M 41.52M 45.26M
Interest Income
n/a n/a n/a n/a
Pretax Income
46.19M 41.21M 29.95M 36.11M
Net Income
31.4M 36.67M 19.45M 19.73M
Selling & General & Admin
38.59M 38.89M 38.12M 44.17M
Research & Development
n/a n/a n/a n/a
Other Expenses
-8.78M 515K -722K -5.59M
Operating Expenses
29.82M 39.41M 37.4M 38.58M
Interest Expense
12.37M 13.43M 11.57M 9.15M
Selling & Marketing Expenses
n/a -1.36M n/a n/a
Cost & Expenses
465.29M 455.15M 448.21M 424.99M
Income Tax Expense
14.03M 4.18M 10.3M 15.89M
Shares Outstanding (Basic)
46.9M 46.68M 46.33M 46.01M
Shares Outstanding (Diluted)
47.69M 47.52M 46.81M 46.69M
EPS (Basic)
0.67 0.79 0.42 0.43
EPS (Diluted)
0.66 0.77 0.42 0.42
EBITDA
73.27M 70.42M 58.69M 63.78M
EBIT
58.56M 54.64M 41.52M 45.26M
Depreciation & Amortization
14.95M 15.78M 17.16M 18.52M